rs3735942
Positions:
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1
The ENST00000262209.5(TRPA1):c.1644+15C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.352 in 1,586,502 control chromosomes in the GnomAD database, including 102,778 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.37 ( 10927 hom., cov: 32)
Exomes 𝑓: 0.35 ( 91851 hom. )
Consequence
TRPA1
ENST00000262209.5 intron
ENST00000262209.5 intron
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.554
Genes affected
TRPA1 (HGNC:497): (transient receptor potential cation channel subfamily A member 1) The structure of the protein encoded by this gene is highly related to both the protein ankyrin and transmembrane proteins. The specific function of this protein has not yet been determined; however, studies indicate the function may involve a role in signal transduction and growth control. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -20 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 8-72053738-G-A is Benign according to our data. Variant chr8-72053738-G-A is described in ClinVar as [Benign]. Clinvar id is 1342281.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.531 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRPA1 | NM_007332.3 | c.1644+15C>T | intron_variant | ENST00000262209.5 | NP_015628.2 | |||
MSC-AS1 | NR_033652.1 | n.2228G>A | non_coding_transcript_exon_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRPA1 | ENST00000262209.5 | c.1644+15C>T | intron_variant | 1 | NM_007332.3 | ENSP00000262209 | P1 | |||
MSC-AS1 | ENST00000518916.5 | n.469+1122G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.370 AC: 56278AN: 151962Hom.: 10903 Cov.: 32
GnomAD3 genomes
AF:
AC:
56278
AN:
151962
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.398 AC: 98558AN: 247362Hom.: 21490 AF XY: 0.383 AC XY: 51157AN XY: 133520
GnomAD3 exomes
AF:
AC:
98558
AN:
247362
Hom.:
AF XY:
AC XY:
51157
AN XY:
133520
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.350 AC: 502436AN: 1434422Hom.: 91851 Cov.: 25 AF XY: 0.347 AC XY: 248008AN XY: 714740
GnomAD4 exome
AF:
AC:
502436
AN:
1434422
Hom.:
Cov.:
25
AF XY:
AC XY:
248008
AN XY:
714740
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.370 AC: 56344AN: 152080Hom.: 10927 Cov.: 32 AF XY: 0.376 AC XY: 27963AN XY: 74320
GnomAD4 genome
AF:
AC:
56344
AN:
152080
Hom.:
Cov.:
32
AF XY:
AC XY:
27963
AN XY:
74320
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1616
AN:
3478
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:1
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Familial episodic pain syndrome with predominantly upper body involvement Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Sep 10, 2021 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at